Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chalmers, A. Singanayagam, M. Murray, A. Hill (Edinburgh, United Kingdom). Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired pneumonia. Eur Respir J 2008; 32: Suppl. 52, 1850

Member's Comments

No comment yet.

Related content which might interest you: D-dimer is an independent marker predicting severity in community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Elevated creatinine is a sensitive severity marker in community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002 Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia Source: Annual Congress 2008 - Airway infection and host defence Year: 2008 Total antioxidant capacity and C-reactive protein levels in patients with community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Influence of older age on biomarker concentrations in patients with community acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Plasma levels of LL37 in patients with and at risk of acute lung injury Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Elevated plasma EPCR levels early post ICU admission predict sepsis development Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007